Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Abramowicz

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|June 6, 1998
Daclizumab to prevent acute rejection in renal transplantationD Abramowicz
Revue Medicale De Bruxelles|November 1, 1988
[Immunosuppression: antilymphocyte antibodies]D Abramowicz
Transplantation Proceedings|March 20, 1999
Induction protocols: yesterday, today, and tomorrowD Abramowicz, M Wissing
Transplantation|September 15, 1996
Efficacy of rejection prophylaxis with OKT3D Abramowicz, M Goldman
La Revue Du Praticien|January 1, 1994
[Allogenic reaction, a model of autoimmunity]M Goldman, D Abramowicz
The New England Journal of Medicine|September 3, 1992
Anaphylactic shock after retreatment with OKT3 monoclonal antibodyD Abramowicz, A Crusiaux, M Goldman
The New England Journal of Medicine|July 11, 1998
Hepatitis B virus infectionD Abramowicz, C Blanpain, C Knoop
The New England Journal of Medicine|August 11, 1994
HLA compatibility and graft survival after heart transplantationP Vereerstraeten, D Abramowicz, M Andrien
Presse Medicale (Paris, France : 1983)|November 2, 1985
[Allogenic interactions in immunopathology]M Goldman, D Abramowicz, C Bruyns
The New England Journal of Medicine|January 5, 2000
Drug treatment of lipid disordersN Broeders, C Knoop, D Abramowicz
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|June 6, 1998
Daclizumab to prevent acute rejection in renal transplantationD Abramowicz
Revue Medicale De Bruxelles|November 1, 1988
[Immunosuppression: antilymphocyte antibodies]D Abramowicz
Transplantation Proceedings|March 20, 1999
Induction protocols: yesterday, today, and tomorrowD Abramowicz, M Wissing
Transplantation|September 15, 1996
Efficacy of rejection prophylaxis with OKT3D Abramowicz, M Goldman
La Revue Du Praticien|January 1, 1994
[Allogenic reaction, a model of autoimmunity]M Goldman, D Abramowicz
The New England Journal of Medicine|September 3, 1992
Anaphylactic shock after retreatment with OKT3 monoclonal antibodyD Abramowicz, A Crusiaux, M Goldman
The New England Journal of Medicine|July 11, 1998
Hepatitis B virus infectionD Abramowicz, C Blanpain, C Knoop
The New England Journal of Medicine|August 11, 1994
HLA compatibility and graft survival after heart transplantationP Vereerstraeten, D Abramowicz, M Andrien
Presse Medicale (Paris, France : 1983)|November 2, 1985
[Allogenic interactions in immunopathology]M Goldman, D Abramowicz, C Bruyns
The New England Journal of Medicine|January 5, 2000
Drug treatment of lipid disordersN Broeders, C Knoop, D Abramowicz
Pageof 16